ChemicalBook > CAS DataBase List > SB1317

SB1317

Product Name
SB1317
CAS No.
937270-47-8
Chemical Name
SB1317
Synonyms
CS-915;TG02;TG-02;(E/Z)-TG02;(E/Z)-SB1317;SB1317, >=98%;TG-02/SB-1317;(E/Z)-Zotiraciclib;Zotiraciclib free base;Zotiraciclib (SB1317) HCl;SB1317(TG-02) hydrochloride
CBNumber
CB32628476
Molecular Formula
C23H24N4O
Formula Weight
372.46
MOL File
937270-47-8.mol
More
Less

SB1317 Property

Boiling point:
575.5±60.0 °C(Predicted)
Density 
1.16±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in H2O; ≥44.87 mg/mL in DMSO; ≥3.98 mg/mL in EtOH with gentle warming and ultrasonic
form 
solid
pka
8.03±0.20(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

TRC
Product number
T337705
Product name
TG02
Packaging
5mg
Price
$140
Updated
2021/12/16
Biosynth Carbosynth
Product number
BS167349
Product name
SB 1317
Packaging
25mg
Price
$150
Updated
2021/12/16
Biosynth Carbosynth
Product number
BS167349
Product name
SB 1317
Packaging
10mg
Price
$125
Updated
2021/12/16
Biosynth Carbosynth
Product number
BS167349
Product name
SB 1317
Packaging
100mg
Price
$375
Updated
2021/12/16
Biosynth Carbosynth
Product number
BS167349
Product name
SB 1317
Packaging
50mg
Price
$437.5
Updated
2021/12/16
More
Less

SB1317 Chemical Properties,Usage,Production

Uses

TG 02 is a cyclin dependent kinase inhibitors (CDK inhibitors) for the treatment of chronic lymphocytic leukemia.

SB1317 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

SB1317 Suppliers

China 61 United Kingdom 1 United States 10 Global 72

937270-47-8, SB1317Related Search:

SB-649868 SB 204741 SB1317 SB216763 Sb-742457 MMP-2/MMP-9 INHIBITOR IV SB 242084 (hydrochloride) SB 415286 SB 202190 SB 431542 5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime SB 269970 HYDROCHLORIDE 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline 4'-CHLORO-3-METHOXYCINNAMANILIDE SB-705498 SB 203580 SB242235 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride

  • TG-02/SB-1317
  • 14-Methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
  • SB1317, >=98%
  • SB1317(TG-02) hydrochloride
  • CS-915
  • TG02; SB 1317; TG 02; SB-1317; TG-02
  • TG02;TG-02
  • 20-Oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-
  • (E/Z)-SB1317
  • (E/Z)-TG02
  • (E/Z)-Zotiraciclib
  • Zotiraciclib free base
  • Zotiraciclib (SB1317) HCl
  • multiple myeloma,JAK2,Fms like tyrosine kinase 3,Cyclin dependent kinase,JAK,FLT3,Janus kinase,CD135,leukemias,Inhibitor,CDK,CDK2,Cluster of differentiation antigen 135,inhibit,cancer,(E/Z)-Zotiraciclib,(E/Z) Zotiraciclib,(E/Z)Zotiraciclib
  • 6-Methyl-12-oxa-3,6-diaza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene
  • 937270-47-8